Rafarma Pharmaceuticals Commences Preparation Of Audited Financials

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to upgrading its public stock listing. Rafarma has engaged RBSM, LLP, a highly-regarded accounting firm registered with the Public Company Accounting Oversight Board to conduct its independent financial audit. - See more at: http://www.globenewswire.com/news-release/2014/05/12/635428/10081208/en/Rafarma-Pharmaceuticals-RAFA-Commences-Preparation-of-Audited-Financials.html#sthash.7F4jTSox.dpuf

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC